HCPCS code J0885: Epoetin alfa, per 1,000 units2026 Medicare rate & RVUs in Missouri
Reports epoetin alfa furnished for non-ESRD use, with each HCPCS unit representing 1,000 units of the drug administered.
CMS doesn’t publish an office rate for J0885 in Missouri.
Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.
Your location
On this page 9 sections
What J0885 covers
Epoetin alfa is an erythropoiesis-stimulating drug used to treat anemia, including anemia associated with chronic kidney disease in patients not receiving dialysis and anemia related to certain cancer treatments. It is typically administered by a clinician in an office, clinic, or hospital outpatient setting, by subcutaneous injection or intravenous administration. The non-ESRD designation distinguishes this code from codes for use in end-stage renal disease (ESRD); it does not identify a particular anemia cause or route.
CMS assigns this code physician fee schedule status E, meaning it is excluded from the physician fee schedule. When Medicare covers the drug, payment is under another payment method; as a Part B drug, it is generally priced using CMS quarterly Average Sales Price drug pricing files. Special Medicare coverage instructions apply. Each HCPCS unit represents 1,000 units of epoetin alfa, so a 40,000-unit dose corresponds to 40 HCPCS units.
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Where J0885 pays more and less in Missouri
The same RVUs, adjusted for each area’s costs. Open a locality for its calculation, history and nearby areas.
| Payment locality | Office | Facility |
|---|---|---|
| Metropolitan Kansas City, MO | Unavailable | Unavailable |
| Metropolitan St. Louis, MO | Unavailable | Unavailable |
| Rest of Missouri | Unavailable | Unavailable |
How the J0885 rate is calculated
Each of J0885’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.
How the rate is built · J0885
RVUs × geographic indexes × conversion factor
Work0.00
0.00 RVUs× 1.000 GPCI
Practice expense0.00
0.00 RVUs× 1.000 GPCI
Malpractice0.00
0.00 RVUs× 1.000 GPCI
Adjusted RVUs
0.0000
Conversion factor
$33.4009
Medicare rate
$0.00
Every GPCI starts at 1.000, the national rate. Enter a ZIP or drag a slider.
Payment rules and modifiers for J0885
J0885 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.
Place of service · J0885
Which rate does Medicare pay?
The POS code on the claim line (CMS-1500 box 24B).
POS 11 · non-facility rate · national
—
J0885 isn’t priced in this setting.
J0885 compared with similar codes
Compare codes · National
4 codes, side by side
How to choose
- J0881Darbepoetin alfaPer 1 mcg, non-ESRD
- Both are non-ESRD anemia drugs, but J0885 reports epoetin alfa and J0881 reports darbepoetin alfa.
- J0882Darbepoetin alfaESRD on dialysis, per 1 mcg
- J0882 reports darbepoetin alfa for ESRD use. J0885 reports epoetin alfa for non-ESRD use.
- J0888Epoetin betaPer 1 mcg
- J0888 reports epoetin beta for non-ESRD use; J0885 reports epoetin alfa for non-ESRD use.
J0885 billing questions
How does J0885 differ from J0881?
J0885 is for non-ESRD epoetin alfa. J0881 is for non-ESRD darbepoetin alfa, a different erythropoiesis-stimulating drug.
How many HCPCS units should be reported?
Each unit represents 1,000 units of epoetin alfa. Divide the administered dose in drug units by 1,000; for example, 40,000 drug units equal 40 HCPCS units.
Does J0885 identify the route of administration?
No. The code identifies the drug and its non-ESRD use, not whether it was administered subcutaneously or intravenously.
Does Medicare pay J0885 under the physician fee schedule?
No. CMS assigns status E, excluding it from the physician fee schedule. When Medicare covers it, the drug is paid under another method and is generally priced through CMS quarterly ASP drug pricing files.
Can J0885 be used for an ESRD patient?
J0885 is designated for non-ESRD use and should not be selected to report ESRD use.
Is the drug administration included in J0885?
J0885 reports the drug quantity, not the act of administering it. An administration service may be reported separately when supported by the circumstances and applicable coding requirements.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.
CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027
Fee sheets · Coming soon
Put J0885 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist